Evidence map›Paper›PMID 41398330›Full record

ArticleScientific reports2025

Numerical computation of the stochastic hepatitis B model using feed forward neural network and real data.

Tahir Khan, Il Hyo Jung

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tahir KhanInstitute of Mathematical Sciences, Pusan National University, Busan, 46241, South Korea. tahirmaths200014@gmail.com.
Il Hyo JungInstitute of Mathematical Sciences, Pusan National University, Busan, 46241, South Korea. ilhjung@pusan.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B is a global health burden and can persist for years, with nearly two billion infections worldwide, where its spread is influenced by environmental heterogeneity, host-pathogen interactions, and vaccination-induced immune variability. Proper understanding and developing models with a suitable framework is essential to accurately capture the complexity of the hepatitis B virus (HBV) and its transmission. In this work, we present a novel framework of a stochastic model and a forward neural network that combines neural networks and stochastic differential equations to analyze the dynamics of hepatitis B virus transmission, as it is important to capture the inherent uncertainty of disease spread in heterogeneous environments. We formulate the stochastic model with a saturated incidence rate, incorporating the long-term persistence of the disease following key characteristics of the disease transmission. The theoretical analysis of the model is proven to ensure the well-posedness and to determine the conditions for extinction and persistence of the disease. Further, a set of real data of hepatitis B reported cases will be used to produce stochastic simulations, and to train a feed-forward neural network (FFNN), while approximating the model dynamics more effectively. To evaluate the efficacy of the hybrid framework, we demonstrate its performance by the presenting mean squared error (MSE), absolute error (AE), and regression analysis showing strong agreement between the stochastic simulations and neural network predictions.

Indexed as

Hepatitis BHepatitis B virusModels, BiologicalNeural Networks, ComputerComputer SimulationHumansStochastic ProcessesFeed forward neural network and optimizationHepatitis B virusNumerical simulationsSaturated incidenceStochastic differential equations

Identifiers

PMID41398330
PMCPMC12706004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.